Vanda Pharmaceuticals Inc. (VNDA) Insider Trading -- Recent Executive & Director Transactions

12 insiders reported 30 Form 4 transactions for Vanda Pharmaceuticals Inc. (VNDA) over the past 18 months (most recent 2026-06-08). Recent activity: DUGAN RICHARD W (Director) Buy 41,600 shares, Mitchell Stephen Ray (Director) Buy 41,600 shares, McGuire Daniel Patrick (SVP, GC and Secretary) Buy 80,000 shares, Honore Tage (Director) Buy 41,600 shares, Chrousos Phaedra (Director) Buy 41,600 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-08DUGAN RICHARD WDirectorBuy41,600$0
2026-06-08Mitchell Stephen RayDirectorBuy41,600$0
2026-06-08McGuire Daniel PatrickSVP, GC and SecretaryBuy80,000$0
2026-06-08Honore TageDirectorBuy41,600$0
2026-06-08Chrousos PhaedraDirectorBuy41,600$0
2026-06-08Ward Anne SempowskiDirectorBuy41,600$0
2026-06-08Duncan Charles CliffDirectorBuy41,600$0
2026-05-20Mitchell Stephen RayDirectorSell25,836$0
2026-04-24Duncan Charles CliffDirectorBuy57,101$0
2026-03-04Moran Kevin PatrickSVP, CFO & TreasurerSell42,442$350,995
2026-03-04Birznieks GuntherSVP, Business DevelopmentSell42,431$350,904
2026-03-04Williams TimothySVP & General CounselSell42,434$350,929
2026-03-04Wijkstrom JoakimSVP, Chief Marketing OfficerSell30,800$254,716
2026-03-04Polymeropoulos Mihael HristosPresident and CEOSell156,235$1.3M
2026-02-24Honore TageDirectorSell30,000$240,900
2026-02-19Moran Kevin PatrickSVP, CFO & TreasurerBuy125,000$0
2026-02-19Wijkstrom JoakimSVP, Chief Marketing OfficerBuy125,000$0
2026-02-19Birznieks GuntherSVP, Business DevelopmentBuy125,000$0
2026-02-19Polymeropoulos Mihael HristosPresident and CEOBuy525,000$0
2026-02-19Williams TimothySVP & General CounselBuy125,000$0
2025-08-08Polymeropoulos Mihael HristosPresident and CEOBuy10,000$41,500
2025-06-16Mitchell Stephen RayDirectorSell7,000$32,130
2025-06-09Chrousos PhaedraDirectorBuy59,225$0
2025-06-09Ward Anne SempowskiDirectorBuy59,225$0
2025-06-09Honore TageDirectorBuy59,225$0

来源:SEC Form 4 申报文件 · 截至 2026-06-08